Immunohistochemical analysis of cyclin A in astrocytic tumours

作者: Chakrabarty , Bridges

DOI: 10.1046/J.1365-2990.1998.00114.X

关键词:

摘要: Cyclins are important regulators of the cell cycle; there is increasing evidence that some cyclins positively involved in carcinogenesis. Amplification and translocation cyclin genes overexpression their mRNAs proteins have been observed a variety tumours. We studied A protein astrocytic tumours by immunohistochemical analysis. Immunohistochemistry with microwave antigen retrieval was carried out on formalin fixed, paraffin embedded material from 15 glioblastomas (WHO grade IV), 10 anaplastic astrocytomas III), seven diffuse low II) nine pilocytic I) using antibodies against proliferation marker MIB1. Staining for these seen mainly tumour nuclei; 66% all cases showing staining 95% Mean labelling indices (LI) were higher glioblastoma (mean LI-6.7) astrocytoma LI-5.9) than LI-1.7) LI-0.12), although no clear cut off point between various types. good correlation MIB1 (Pearson coefficient r = 0.59, P < 0.0001). Cyclin variably expressed tumours, either reflecting increased (cyclin being an integral component cycle), alteration its gene, upregulation or regulation apoptosis. The genetic basis expression remains to be determined.

参考文章(38)
B. Tycko, M. Sisti, Luwa Yuan, T. Moulton, Ghassan Samara, J. Bruce, Raj Desai, Wai-Yee Chung, MTS1/p16/CDKN2 lesions in primary glioblastoma multiforme. American Journal of Pathology. ,vol. 146, pp. 613- 619 ,(1995)
J.A. Knoblich, C.F. Lehner, Synergistic action of Drosophila cyclins A and B during the G2-M transition. The EMBO Journal. ,vol. 12, pp. 65- 74 ,(1993) , 10.1002/J.1460-2075.1993.TB05632.X
G Reifenberger, K Ichimura, V P Collins, E E Schmidt, CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Research. ,vol. 54, pp. 6321- 6324 ,(1994)
Jin Jen, J Wade Harper, Sandra H Bigner, Darell D Bigner, Nickolas Papadopoulos, Sanford Markowitz, James KV Willson, Kenneth W Kinzler, Bert Vogelstein, None, Deletion of p16 and p15 Genes in Brain Tumors Cancer Research. ,vol. 54, pp. 6353- 6358 ,(1994)
O. Kranenburg, A. J. van der Eb, A. Zantema, Cyclin D1 is an essential mediator of apoptotic neuronal cell death. The EMBO Journal. ,vol. 15, pp. 46- 54 ,(1996) , 10.1002/J.1460-2075.1996.TB00332.X
M. Pagano, R. Pepperkok, F. Verde, W. Ansorge, G. Draetta, Cyclin A is required at two points in the human cell cycle. The EMBO Journal. ,vol. 11, pp. 961- 971 ,(1992) , 10.1002/J.1460-2075.1992.TB05135.X
Andreas von Deimling, Jimmy T. Efird, John W. Henson, David N. Louis, Yasuhiro Ono, Keisuke Ueki, CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated Cancer Research. ,vol. 56, pp. 150- 153 ,(1996)
Gaetano Finocchiaro, Cristiana Giani, Mutation Rate of the CDKN2 Gene in Malignant Gliomas Cancer Research. ,vol. 54, pp. 6338- 6339 ,(1994)
M. O. Adeyanju, O. I. Olopade, S. K. Bohlander, M. H. Dreyling, Detection of CDKN2 Deletions in Tumor Cell Lines and Primary Glioma by Interphase Fluorescence in Situ Hybridization Cancer Research. ,vol. 55, pp. 984- 988 ,(1995)
Jirina Bartkova, Jiri Lukas, Jiri Bartek, Barry Gusterson, Heiko Müller, Michael Strauss, Abnormal Patterns of D-Type Cyclin Expression and G1 Regulation in Human Head and Neck Cancer Cancer Research. ,vol. 55, pp. 949- 956 ,(1995)